Skip to content
Screener

Shattuck Labs, Inc. STTK Investing Cash Flow

Investing Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
-$15.4B-739%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$1.11B+93.9%
Amgen logo
AmgenAMGN
-$569M-46.3%
AbbVie logo
AbbVieABBV
-$574M+21.9%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-$30.93M-262%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$329.93M-366%

Other financials

Income statement

See full
Revenue-
Operating income-$16.2M-24.0%
Net income-$15.2M-21.6%
EPS (diluted)-$0.12+50.0%

Balance sheet

See full
Cash & equivalents$63.3M+25.4%
Total debt$2.7M-10.0%
Total equity$211.1M+270%
Total assets$220.7M+243%

Cash flow

See full
Operating cash flow-$10.2M+2.4%
CapEx$78.0K
Free cash flow-$10.3M+1.6%

Valuation

See full
Market cap$681.93M+1,826%
Enterprise value$621.3M-5,241%
P/S681.9×+670×

Profitability

See full
Operating margin-5,578.7%-15,316pp
Net margin-5,256.8%-14,625pp
FCF margin-4,124%-23,818pp

Returns & leverage

See full
Return on equity-39.2%-12.5pp
Debt / equity0.0×
Current ratio27.6×+17.3×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Shattuck Labs, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 6:57 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055483
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Maturities of investments23,91415,600
Purchases of investments(144,871)
Purchase of property and equipment(141)
Net cash (used in) provided by investing activities(121,098)15,600
Cash flows from financing activities:
Proceeds from sale of common stock, pre-funded warrants and common stock warrants, net of offering costs100,989
Proceeds from the exercise of common stock warrants52,778
Proceeds from the exercises of stock options and purchases pursuant to employee stock purchase plan3168

Item 1. Condensed Financial Statements (Unaudited)

FAQ

What is Shattuck Labs, Inc.'s investing cash flow?
Shattuck Labs, Inc. (STTK) reported investing cash flow of -$144.95M in Q2 2026.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Shattuck Labs, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude